Corgard

Roman name

Corgard #

The composition and the form of

1 tablet contains nadolola 40, or 80 mg; Patients in the 20, 30 or 100 pc. or blister package 14, 20 or 28 pieces.

Of drugs

Antianginalnoe, gipotenzivne, antiaritmicescoe. Lock and beta_1- бета_2-адренорецептор��.

Farmakodinamika

Provides protection from excessive sympathetic activity, reduce the need heart of oxygen at any level loads. Decreases often migraine attacks (prevents vazokonstricciu in the inner artery sleeping and overnutrition adrenergic impulsaciu, leading to the expansion of the outer sleeping artery).

Clinical pharmacology

Decreases the number and severity of strokes by blocking the effect kateholaminova stimulation. Reduces rate by preventing repeat heart attacks and episodes of sudden death in patients emerging from the first myocardial infarction.

Indications

Angina, hypertension, irregular, migraine (prevention), thyrotoxicosis (withdrawal symptoms gipertireoidisme and preparations for the surgery).

Contraindications

Bronchial asthma, sinusova aetiology, AV blockade II extent cardiogenny shock female heart failure.

Side-Effects

Aetiology, gipotenzia, parestesia, dry mouth, a breach by the stomach, insomnia.

Precautions

Be wary appoint patients with psoriazom.

Dosing and Administration

Inside, every day. Angina, incredible, migraine, from 40 to 160 mg per day. Thyrotoxicosis-160 mg per day. Hypertension, ranging from 80 to 240 mg per day.

Storage conditions

table. : List B. At room temperature no higher than 30 ° C

Directory → Wegetotropona funds → Adrainoliticaskie funds → Beta-adrenoblokatora → Corgard